HLS Therapeutics Inc T.HLS

Alternate Symbol(s): HLTRF

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Psychiatry and Vascepa. Its Clozaril is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. The Vascepa (icosapent ethyl capsules) is a single-molecule prescription product in use to reduce the risk of cardiovascular events.

TSX:HLS - Post by User

HLS Therapeutics Inc

Bullboard Posts

Comment by LTOWNERon Jan 04, 2013 6:35am

242 Views

Post# 20796602

RE: Harper at Ford this morning

Nice catch b4545 - Good for AM perhaps. "OAKVILLE, Ont. – Prime Minister Stephen Harper is scheduled to make a stop at the Ford plant in Oakville, Ont., Friday afternoon, to announce a multi-million-dollar subsidy program for the auto industry ,,,They’re expected to announce that the five-year “automotive innovative fund,” which the Harper established in 2008 to help the industry recover, will be renewed, setting aside $250-million for car companies and their suppliers."

Bullboard Posts

A Look into the Future of Chronic Pain Management